Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Neuroscience|March 5, 2017
Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stressLaura A Grafe, Darrell Eacret, Sandra Luz, et al.Behavioural Brain Research|June 15, 2018
Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memoryDarrell Eacret, Laura A Grafe, Jane Dobkin, et al.Molecular Neurodegeneration|November 2, 2010
Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of ratsSokreine Suon, Jie Zhao, Stephanie A Villarreal, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 2013
Biphasic cholinergic synaptic transmission controls action potential activity in thalamic reticular nucleus neuronsYan-Gang Sun, Juan D Pita-Almenar, Chia-Shan Wu, et al.Depression and Anxiety|September 3, 2015
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSESPhilip L Johnson, Lauren M Federici, Stephanie D Fitz, et al.Sleep Medicine|October 27, 2015
New approach for analyzing self-reporting of insomnia symptoms reveals a high rate of comorbid insomnia across a wide spectrum of chronic diseasesBozena Katic, James Heywood, Fred Turek, et al.Neuropharmacology|June 6, 2015
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodentsRenee C Gentzel, Dawn Toolan, Rhonda Roberts, et al.Psychopharmacology|December 11, 2014
Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkeyJoshua D Vardigan, Christopher E Cannon, Vanita Puri, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 2015
Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem CellsMarija Usenovic, Shahriar Niroomand, Robert E Drolet, et al.The Journal of Clinical Investigation|April 6, 2021
Parkinson disease among patients treated for benign prostatic hyperplasia with α1 adrenergic receptor antagonistsRahul Sasane, Amy Bartels, Michelle Field, et al.Pageof 12